Reports Q3 revenue C$74.8M vs. C$78.5M last year. “Canopy Growth’s (CGC) third quarter highlights that our business has the right ingredients ...

Be cautious ahead of Canopy Growth Corporation's FQ3 results, as weak financials and low margins may hinder stock performance ...

Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (Nasdaq: CGC) today announces its financial results ...

Canopy Growth Corporation股票所在的制药行业中，整体涨幅为0.91%。其相关个股中，Quantum Biopharma Ltd.、坎伯兰药业、Incannex Healthcare Inc.涨幅较大，Quantum Biopharma Ltd.、坎伯兰药业、大自然药业较为活跃，换手率分别为3178.15%、82.10%、18.45%，振幅较大的相关个股有Quantum ...

Canopy Growth Corporation’s CGC share price has surged by 22.22%, which has investors questioning if this is right time to sell.

北京时间2025年02月01日02时59分，Canopy Growth Corporation（CGC.us）股票出现波动，股价快速下挫5.24%。截至发稿，该股报1.99美元/股，成交量313.1万股， 换手率 2.56%，振幅6.19%。

Canopy Growth (NASDAQ:CGC – Get Free Report) is anticipated to issue its quarterly earnings data before the market opens on ...

Investorideas , a go-to platform for big investing ideas, including cannabis stocks reports on trading for Canopy Growth Corporation (TSX: WEED ) (N ...

The most recent trading session ended with Canopy Growth Corporation (CGC) standing at $1.97, reflecting a -1.01% shift from the previouse trading day's closing. This move lagged the S&P 500's daily ...

Aurora Cannabis (NASDAQ: ACB) surged 45% after reporting record earnings, boosting CGC, TLRY, and CRON stocks.

Cannabis stocks Tilray (TLRY) and Canopy Growth (CGC) rallied 7% and 22.2%, respectively, on Wednesday. One of the key drivers of this upside ...